Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis-Reference-Cited by-同舟云学术

Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis

Published:2010-04-06 Issue:8 Volume:62 Page:2476-2487
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Yoshizaki Ayumi,Yanaba Koichi,Yoshizaki Asako,Iwata Yohei,Komura Kazuhiro,Ogawa Fumihide,Takenaka Motoi,Shimizu Kazuhiro,Asano Yoshihide,Hasegawa Minoru,Fujimoto Manabu,Sato Shinichi

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference49 articles.

1. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis;LeRoy;J Rheumatol,1988

2. Antinuclear antibody in systemic sclerosis (scleroderma);Okano;Rheum Dis Clin North Am,1996

3. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells;Sato;Arthritis Rheum,2004

4. Early T cell activation in the skin from patients with systemic sclerosis;Kalogerou;Ann Rheum Dis,2005

5. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis;Cells;2024-07-17

2. Metabolic control of pathogenesis in autoimmune diseases;The Rose and Mackay Textbook of Autoimmune Diseases;2024

3. Inhibition of the mTORC1 pathway alleviates adipose tissue fibrosis;Heliyon;2023-11

4. Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies;Frontiers in Pharmacology;2023-07-27

5. The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds;Cells;2023-06-20